195 related articles for article (PubMed ID: 34532636)
1. Status report on the atopic dermatitis registry TREATgermany.
Siegels D; Haufe E; Heinrich L; Werfel T; Weidinger S; Schmitt J;
Allergol Select; 2021; 5():274-286. PubMed ID: 34532636
[TBL] [Abstract][Full Text] [Related]
2. Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREATgermany.
Heratizadeh A; Haufe E; Stölzl D; Abraham S; Heinrich L; Kleinheinz A; Wollenberg A; Weisshaar E; Augustin M; Wiemers F; Zink A; von Kiedrowski R; Hilgers M; Worm M; Pawlak M; Sticherling M; Fell I; Handrick C; Schäkel K; Staubach-Renz P; Asmussen A; Schwarz B; Bell M; Effendy I; Bieber T; Homey B; Gerlach B; Tchitcherina E; Stahl M; Schwichtenberg U; Rossbacher J; Buck P; Mempel M; Beissert S; Biedermann T; Weidinger S; Schmitt J; Werfel T;
J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):1263-1272. PubMed ID: 31721316
[TBL] [Abstract][Full Text] [Related]
3. Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermany.
Schmitt J; Abraham S; Trautmann F; Stephan V; Fölster-Holst R; Homey B; Bieber T; Novak N; Sticherling M; Augustin M; Kleinheinz A; Elsner P; Weidinger S; Werfel T
J Dtsch Dermatol Ges; 2017 Jan; 15(1):49-59. PubMed ID: 27862987
[TBL] [Abstract][Full Text] [Related]
4. Atopic dermatitis: disease characteristics and comorbidities in smoking and non-smoking patients from the TREATgermany registry.
Pilz AC; Schielein MC; Schuster B; Heinrich L; Haufe E; Abraham S; Heratizadeh A; Harder I; Kleinheinz A; Wollenberg A; Wiemers F; Weisshaar E; Augustin M; von Kiedrowski R; Pawlak M; Schäkel K; Wildberger J; Hilgers M; Werfel T; Weidinger S; Schmitt J; Biedermann T; Zink A;
J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):413-421. PubMed ID: 34743344
[TBL] [Abstract][Full Text] [Related]
5. [Decreased professional performance and quality of life in patients with moderate-to-severe atopic eczema : Results from the German atopic eczema registry TREATgermany].
Haufe E; Abraham S; Heratizadeh A; Harder I; Zink A; Weisshaar E; Kleinheinz A; von Kiedrowski R; Worm M; Bell M; Wollenberg A; Neubert K; Staubach-Renz P; Hilgers M; Bieber T; Fell I; Homey B; Effendy I; Mempel M; Schäkel K; Beissert S; Weidinger S; Werfel T; Schmitt J
Hautarzt; 2018 Oct; 69(10):815-824. PubMed ID: 30191254
[TBL] [Abstract][Full Text] [Related]
6. High recurrence rate of eczema herpeticum in moderate/severe atopic dermatitis -TREATgermany registry analysis.
Traidl S; Heinrich L; Siegels D; Rösner L; Haufe E; Harder I; Abraham S; Ertner K; Kleinheinz A; Schäkel K; Wollenberg A; Effendy I; Quist S; Asmussen A; Wildberger J; Weisshaar E; Wiemers F; Brücher JJ; Weidinger S; Schmitt J; Werfel T;
J Dtsch Dermatol Ges; 2023 Dec; 21(12):1490-1498. PubMed ID: 37814394
[TBL] [Abstract][Full Text] [Related]
7. Obesity is linked to disease severity in moderate to severe atopic dermatitis-Data from the prospective observational TREATgermany registry.
Traidl S; Hollstein MM; Kroeger N; Fischer S; Heratizadeh A; Heinrich L; Kind B; Siegels D; Abraham S; Schäfer T; Augustin M; Harder I; Pinter A; Schäkel K; Wollenberg A; Ertner K; Ramaker-Brunke J; Bong A; Quist S; Gorriahn-Maiterth H; Schenck F; Sticherling M; Effendy I; Schwarz B; Handrick C; Asmussen A; Weidinger S; Schmitt J; Werfel T;
J Eur Acad Dermatol Venereol; 2024 Apr; ():. PubMed ID: 38661511
[TBL] [Abstract][Full Text] [Related]
8. Itch, sleep loss, depressive symptoms, fatigue, and productivity loss in patients with moderate-to-severe atopic dermatitis: Analyses of TREATgermany registry data.
Birkner T; Siegels D; Heinrich L; Haufe E; Abraham S; Heratizadeh A; Harder I; Bell M; Fell I; Worm M; Handrick C; Effendy I; Asmussen A; Kleinheinz A; Homey B; Sticherling M; Hong-Weldemann SH; Augustin M; Weisshaar E; Schäkel K; Schaefer T; Schwarz B; Wiemers F; Brücher JJ; Quist S; Wollenberg A; Biedermann T; Ertner K; von Kiedrowski R; Werfel T; Weidinger S; Schmitt J;
J Dtsch Dermatol Ges; 2023 Oct; 21(10):1157-1168. PubMed ID: 37485573
[TBL] [Abstract][Full Text] [Related]
9. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ).
de Bruin-Weller M; Thaçi D; Smith CH; Reich K; Cork MJ; Radin A; Zhang Q; Akinlade B; Gadkari A; Eckert L; Hultsch T; Chen Z; Pirozzi G; Graham NMH; Shumel B
Br J Dermatol; 2018 May; 178(5):1083-1101. PubMed ID: 29193016
[TBL] [Abstract][Full Text] [Related]
10. TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema.
Bosma AL; Spuls PI; Garcia-Doval I; Naldi L; Prieto-Merino D; Tesch F; Apfelbacher CJ; Arents BWM; Barbarot S; Baselga E; Deleuran M; Eichenfield LF; Gerbens LAA; Irvine AD; Manca A; Mendes-Bastos P; Middelkamp-Hup MA; Roberts A; Seneschal J; Svensson Å; Thyssen JP; Torres T; Vermeulen FM; Vestergaard C; von Kobyletzki LB; Wall D; Weidinger S; Schmitt J; Flohr C
Br J Dermatol; 2020 Jun; 182(6):1423-1429. PubMed ID: 31444799
[TBL] [Abstract][Full Text] [Related]
11. Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis.
Chopra R; Vakharia PP; Sacotte R; Patel N; Immaneni S; White T; Kantor R; Hsu DY; Silverberg JI
Br J Dermatol; 2017 Nov; 177(5):1316-1321. PubMed ID: 28485036
[TBL] [Abstract][Full Text] [Related]
12. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
Blauvelt A; de Bruin-Weller M; Gooderham M; Cather JC; Weisman J; Pariser D; Simpson EL; Papp KA; Hong HC; Rubel D; Foley P; Prens E; Griffiths CEM; Etoh T; Pinto PH; Pujol RM; Szepietowski JC; Ettler K; Kemény L; Zhu X; Akinlade B; Hultsch T; Mastey V; Gadkari A; Eckert L; Amin N; Graham NMH; Pirozzi G; Stahl N; Yancopoulos GD; Shumel B
Lancet; 2017 Jun; 389(10086):2287-2303. PubMed ID: 28478972
[TBL] [Abstract][Full Text] [Related]
13. Perception of the coronavirus pandemic by patients with atopic dermatitis - Results from the TREATgermany registry.
Helmert C; Siegels D; Haufe E; Abraham S; Heratizadeh A; Kleinheinz A; Harder I; Schäkel K; Effendy I; Wollenberg A; Sticherling M; Stahl M; Worm M; Schwichtenberg U; Schwarz B; Rossbacher J; Buck PM; Schenck F; Werfel T; Weidinger S; Schmitt J;
J Dtsch Dermatol Ges; 2022 Jan; 20(1):45-57. PubMed ID: 34958179
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of dupilumab treatment in 95 patients with atopic dermatitis: daily practice data.
de Wijs LEM; Bosma AL; Erler NS; Hollestein LM; Gerbens LAA; Middelkamp-Hup MA; Kunkeler ACM; Nijsten TEC; Spuls PI; Hijnen DJ
Br J Dermatol; 2020 Feb; 182(2):418-426. PubMed ID: 31145810
[TBL] [Abstract][Full Text] [Related]
15. Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma.
Bansal A; Simpson EL; Paller AS; Siegfried EC; Blauvelt A; de Bruin-Weller M; Corren J; Sher L; Guttman-Yassky E; Chen Z; Daizadeh N; Kamal MA; Shumel B; Mina-Osorio P; Mannent L; Patel N; Graham NMH; Khokhar FA; Ardeleanu M
Am J Clin Dermatol; 2021 Jan; 22(1):101-115. PubMed ID: 33481203
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial.
Thaçi D; Simpson EL; Beck LA; Bieber T; Blauvelt A; Papp K; Soong W; Worm M; Szepietowski JC; Sofen H; Kawashima M; Wu R; Weinstein SP; Graham NM; Pirozzi G; Teper A; Sutherland ER; Mastey V; Stahl N; Yancopoulos GD; Ardeleanu M
Lancet; 2016 Jan; 387(10013):40-52. PubMed ID: 26454361
[TBL] [Abstract][Full Text] [Related]
17. Systemic treatments in the management of atopic dermatitis: A systematic review and meta-analysis.
Siegels D; Heratizadeh A; Abraham S; Binnmyr J; Brockow K; Irvine AD; Halken S; Mortz CG; Flohr C; Schmid-Grendelmeier P; Van der Poel LA; Muraro A; Weidinger S; Werfel T; Schmitt J;
Allergy; 2021 Apr; 76(4):1053-1076. PubMed ID: 33074565
[TBL] [Abstract][Full Text] [Related]
18. Dupilumab for children and adolescents with atopic dermatitis: An Asian perspective.
Chia SY; Wee LWY; Koh MJA
Dermatol Ther; 2021 May; 34(3):e14933. PubMed ID: 33751751
[TBL] [Abstract][Full Text] [Related]
19. Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial.
Paller AS; Bansal A; Simpson EL; Boguniewicz M; Blauvelt A; Siegfried EC; Guttman-Yassky E; Hultsch T; Chen Z; Mina-Osorio P; Lu Y; Rossi AB; He X; Kamal M; Graham NMH; Pirozzi G; Ruddy M; Eckert L; Gadkari A
Am J Clin Dermatol; 2020 Feb; 21(1):119-131. PubMed ID: 31823222
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2).
Thaçi D; L Simpson E; Deleuran M; Kataoka Y; Chen Z; Gadkari A; Eckert L; Akinlade B; Graham NMH; Pirozzi G; Ardeleanu M
J Dermatol Sci; 2019 May; 94(2):266-275. PubMed ID: 31109652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
